|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
EBOOKCENTRAL_ocn907647573 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
130702s2012 fluad ob 001 0 eng |
040 |
|
|
|a Nz
|b eng
|e pn
|c UV0
|d OCLCO
|d CRCPR
|d OCLCQ
|d OCLCF
|d OCLCQ
|d OTZ
|d EBLCP
|d U3W
|d NLE
|d AU@
|d UWO
|d MERUC
|d OCLCQ
|d RC0
|d SDF
|d UEJ
|d SFB
|d OCLCO
|d SGP
|d OCLCO
|d SHC
|d OCLCQ
|d OCLCO
|d DXU
|d OCLCL
|
066 |
|
|
|c (S
|
019 |
|
|
|a 1006805896
|a 1051404693
|
020 |
|
|
|a 9781841848617
|q (e-book ;
|q PDF)
|
020 |
|
|
|a 1841848611
|q (e-book ;
|q PDF)
|
029 |
0 |
|
|a NZ1
|b 15900321
|
035 |
|
|
|a (OCoLC)907647573
|z (OCoLC)1006805896
|z (OCoLC)1051404693
|
037 |
|
|
|a TANDF_240971
|b Ingram Content Group
|
050 |
|
4 |
|a RM666.H28
|b H47 2012
|
072 |
|
7 |
|a MED
|x 000000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MB
|2 bicssc
|
082 |
0 |
4 |
|a 615.718
|b H529
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Heparin-induced thrombocytopenia /
|c edited by Theodore E. Warkentin, Andreas Greinacher.
|
250 |
|
|
|a 5th ed.
|
260 |
|
|
|a Boca Raton, Fla. :
|b CRC Press,
|c 2012.
|
300 |
|
|
|a 1 online resource (xi, 641 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Fundamental and Clinical Cardiology
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a 1. History of heparin-induced thrombocytopenia / Theodore E. Warkentin -- 2. Clinical picture of heparin-induced thrombocytopenia / Theodore E. Warkentin -- 3. Differential diagnosis of heparin-induced thrombocytopenia and scoring systems / Theodore E. Warkentin and Adam Cuker -- 4. Frequency of heparin-induced thrombocytopenia / Lori-Ann Linkins and David H. Lee -- 5. Nonimmune heparin-platelet interactions : implications for the pathogenesis of heparin-induced thrombocytopenia / McDonald K. Horne III and Andreas Greinacher -- 6. Role of heparin-dependent antigens in immune heparin-induced thrombocytopenia / Jean Amiral and Anne Marie Vissac -- 7. Role of sulfated polysaccharides and other polyanions in the pathogenesis of heparin-induced thrombocytopenia / Susanne Alban, Krystin Krauel, and Andreas Greinacher -- 8. Platelet and leukocyte Fc? receptors in heparin-induced thrombocytopenia / Gregory A. Denomme -- 9. Cellular and molecular immunopathogenesis of heparin-induced thrombocytopenia / Lubica Rauova, Gowthami M. Arepally, Douglas B. Cines, and Mortimer Poncz -- 10. Murine models of heparin-induced thrombocytopenia / Gowthami M. Arepally, Bruce S. Sachais, Douglas B. Cines, Mortimer Poncz, Lubica Rauova, and Steven E. McKenzie -- 11. Laboratory testing for heparin-induced thrombocytopenia / Theodore E. Warkentin and Andreas Greinacher -- 12. Treatment of heparin-induced thrombocytopenia : an overview / Andreas Greinacher and Theodore E. Warkentin.
|
505 |
8 |
|
|a 13. Argatroban therapy in heparin-induced thrombocytopenia / Lawrence Rice, Martin Beiderlinden, and Marcie J. Hursting -- 14. Recombinant hirudin for the treatment of heparin-induced thrombocytopenia / Andreas Greinacher -- 15. Bivalirudin for the treatment of heparin-induced thrombocytopenia / John R. Bartholomew and Jayne Prats -- 16. Danaparoid for the treatment of heparin-induced thrombocytopenia / Beng Hock Chong and Harry N. Magnani -- 17. Fondaparinux and other emerging anticoagulants to treat heparin-induced thrombocytopenia / Theodore E. Warkentin and John W. Eikelboom -- 18. Hemodialysis in heparin-induced thrombocytopenia / Karl-Georg Fischer -- 19. Management of intraoperative anticoagulation in patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery / Andreas Koster and Sixten Selleng -- 20. Heparin-coated intravascular devices and heparin-induced thrombocytopenia / Theodore E. Warkentin -- 21. Heparin-induced thrombocytopenia in children / Anne F. Klenner and Andreas Greinacher -- 22. A clinician's perspective on heparin-induced thrombocytopenia : paradoxes, myths, and continuing challenges / Lawrence Rice -- 23. Appendices.
|
520 |
|
|
|a Suitable for clinicians and hematology consultants, this title includes: coverage of approved and novel pharmacotherapies, dosing guidelines, and the advantages and limitations of alternative anticoagulants; review of the immune basis and pathogenesis, animal models, and laboratory testing for HIT antibodies; and more.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Thrombocytopenia.
|
650 |
|
0 |
|a Heparin.
|
650 |
|
0 |
|a Anticoagulants (Medicine)
|x Therapeutic use.
|
650 |
|
2 |
|a Heparin
|
650 |
|
6 |
|a Héparine.
|
650 |
|
6 |
|a Anticoagulants
|x Emploi en thérapeutique.
|
650 |
|
7 |
|a Anticoagulants (Medicine)
|x Therapeutic use
|2 fast
|
650 |
|
7 |
|a Heparin
|2 fast
|
650 |
|
7 |
|a Thrombocytopenia
|2 fast
|
700 |
1 |
|
|a Warkentin, Theodore E.,
|d 1960-
|1 https://id.oclc.org/worldcat/entity/E39PCjqKVtDFWkGDjv7BCwv6jy
|
700 |
1 |
|
|a Greinacher, Andreas.
|
758 |
|
|
|i has work:
|a Heparin-induced thrombocytopenia (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGHR6xbtxywQ8B7HxtVPkP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
1 |
|
|z 9781841848600
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5378603
|z Texto completo
|
880 |
8 |
|
|6 505-00
|a Chapter 7: Role of sulfated polysaccharides and other polyanions in the pathogenesis of heparin-induced thrombocytopeniaChapter 8: Platelet and leukocyte Fcγ receptors inheparin-induced thrombocytopenia; Chapter 9: Cellular and molecular immunopathogenesis of heparin-induced thrombocytopenia; Chapter 10: Murine models of heparin-induced thrombocytopenia; Chapter 11: Laboratory testing for heparin-induced thrombocytopenia; Chapter 12: Treatment of heparin-induced thrombocytopenia: An overview; Chapter 13: Argatroban therapy in heparin-induced thrombocytopenia
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5378603
|
938 |
|
|
|a CRC Press
|b CRCP
|n CRC0HE10442PDF
|
994 |
|
|
|a 92
|b IZTAP
|